Command Palette

Search for a command to run...

Clinical Trials · NCT03232112

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

CompletedPhase 2Exenatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Anders Fink-Jensen, MD, DMSci
Enrollment
152
Start date
Aug 2017
Locations
1 site, Denmark
Primary endpoint
Heavy drinking days
View Exenatide compound reference